S&P 500   3,341.63 (-0.30%)
DOW   27,486.09 (-0.36%)
QQQ   276.78 (-0.15%)
AAPL   114.33 (-0.55%)
MSFT   207.81 (-0.78%)
FB   259.28 (+0.96%)
GOOGL   1,459.52 (+0.06%)
AMZN   3,162.68 (-0.36%)
TSLA   427.78 (+1.56%)
NVDA   533.86 (+2.39%)
BABA   277.37 (+0.49%)
CGC   14.46 (+1.76%)
GE   6.10 (-1.61%)
MU   51.03 (+2.63%)
AMD   82.26 (+3.50%)
T   28.29 (-0.32%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   62.24 (-0.97%)
NFLX   494.52 (+0.79%)
DIS   124.61 (-1.10%)
BA   163.66 (-1.46%)
BAC   23.81 (-1.16%)
S&P 500   3,341.63 (-0.30%)
DOW   27,486.09 (-0.36%)
QQQ   276.78 (-0.15%)
AAPL   114.33 (-0.55%)
MSFT   207.81 (-0.78%)
FB   259.28 (+0.96%)
GOOGL   1,459.52 (+0.06%)
AMZN   3,162.68 (-0.36%)
TSLA   427.78 (+1.56%)
NVDA   533.86 (+2.39%)
BABA   277.37 (+0.49%)
CGC   14.46 (+1.76%)
GE   6.10 (-1.61%)
MU   51.03 (+2.63%)
AMD   82.26 (+3.50%)
T   28.29 (-0.32%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   62.24 (-0.97%)
NFLX   494.52 (+0.79%)
DIS   124.61 (-1.10%)
BA   163.66 (-1.46%)
BAC   23.81 (-1.16%)
S&P 500   3,341.63 (-0.30%)
DOW   27,486.09 (-0.36%)
QQQ   276.78 (-0.15%)
AAPL   114.33 (-0.55%)
MSFT   207.81 (-0.78%)
FB   259.28 (+0.96%)
GOOGL   1,459.52 (+0.06%)
AMZN   3,162.68 (-0.36%)
TSLA   427.78 (+1.56%)
NVDA   533.86 (+2.39%)
BABA   277.37 (+0.49%)
CGC   14.46 (+1.76%)
GE   6.10 (-1.61%)
MU   51.03 (+2.63%)
AMD   82.26 (+3.50%)
T   28.29 (-0.32%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   62.24 (-0.97%)
NFLX   494.52 (+0.79%)
DIS   124.61 (-1.10%)
BA   163.66 (-1.46%)
BAC   23.81 (-1.16%)
S&P 500   3,341.63 (-0.30%)
DOW   27,486.09 (-0.36%)
QQQ   276.78 (-0.15%)
AAPL   114.33 (-0.55%)
MSFT   207.81 (-0.78%)
FB   259.28 (+0.96%)
GOOGL   1,459.52 (+0.06%)
AMZN   3,162.68 (-0.36%)
TSLA   427.78 (+1.56%)
NVDA   533.86 (+2.39%)
BABA   277.37 (+0.49%)
CGC   14.46 (+1.76%)
GE   6.10 (-1.61%)
MU   51.03 (+2.63%)
AMD   82.26 (+3.50%)
T   28.29 (-0.32%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   62.24 (-0.97%)
NFLX   494.52 (+0.79%)
DIS   124.61 (-1.10%)
BA   163.66 (-1.46%)
BAC   23.81 (-1.16%)
Log in
NASDAQ:JNCE

Jounce Therapeutics Earnings Date, Estimates & History

$8.18
+0.02 (+0.25 %)
(As of 09/29/2020 01:50 PM ET)
Add
Compare
Today's Range
$7.99
Now: $8.18
$8.24
50-Day Range
$4.67
MA: $6.69
$10.95
52-Week Range
$2.79
Now: $8.18
$11.72
Volume15,788 shs
Average Volume645,389 shs
Market Capitalization$278.68 million
P/E Ratio13.19
Dividend YieldN/A
Beta2.11

Earnings

Jounce Therapeutics (NASDAQ:JNCE) Earnings Information

Jounce Therapeutics last issued its earnings results on August 7th, 2020. The reported ($0.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.72) by $0.10. Jounce Therapeutics has generated $1.66 earnings per share over the last year and currently has a price-to-earnings ratio of 13.2. Jounce Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 5th, 2020 based off prior year's report dates.

Jounce Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Jounce Therapeutics (NASDAQ:JNCE) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.99 EPS
Next Year EPS Consensus Estimate: $-2.64 EPS

Jounce Therapeutics (NASDAQ JNCE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/5/2020
(Estimated)
       
8/7/20206/30/2020($0.72)($0.82)($0.82)Transcript
5/6/20203/31/2020($0.57)($0.78)($0.78)$5.00 millionTranscript
2/27/2020Q4 2019($0.28)($0.68)($0.68)$17.50 millionTranscript
11/7/2019Q3$2.24$2.90$2.90$99.97 million$119.45 millionTranscript
8/7/2019Q2 2019($0.26)($0.21)($0.21)$17.09 million$17.45 millionN/A
5/8/20193/31/2019($0.31)($0.38)($0.38)$14.75 million$10.98 millionN/A
3/6/201912/31/2018($0.35)($0.06)($0.06)$12.86 million$20.10 millionTranscript
11/13/2018Q3 2018($0.34)($0.23)($0.23)$12.80 million$14.53 millionN/A
8/10/2018Q2 2018($0.37)($0.1440)($0.14)$12.47 million$19.38 millionN/A
5/9/2018Q1 2018($0.31)($0.40)($0.40)$13.33 million$11.20 millionTranscript
3/8/2018Q4 2017($0.59)($0.34)($0.39)$14.95 million$13.00 millionTranscript
11/13/2017Q3 2017($0.25)($0.1270)($0.13)$20.00 million$18.10 millionN/A
8/9/2017Q2 2017($0.15)($0.11)($0.11)$19.94 million$20.29 millionListen
5/9/2017Q1 2017($0.09)($0.02)($0.02)$19.71 million$20.30 millionN/A
3/10/201712/31/2016$0.04$0.05$0.05$15.00 million$20.30 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.